![Gossamer Bio, Inc. logo](/logos/GOSS.webp)
Gossamer Bio, Inc.
NASDAQ:GOSS
Overview | Financials
Company Name | Gossamer Bio, Inc. |
Symbol | GOSS |
Currency | USD |
Price | 0.91 |
Market Cap | 205,866,570 |
Dividend Yield | 0% |
52-week-range | 0.453 - 1.6 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Faheem Hasnain |
Website | https://www.gossamerbio.com |
An error occurred while fetching data.
About Gossamer Bio, Inc.
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD